We are excited to announce that AusperBio has successfully raised $37 million in funding to further advance its pioneering work in targeted delivery technologies and oligonucleotide therapeutics. As a clinical-stage biopharmaceutical company operating in both the USA and China, AusperBio is committed to addressing some of the most pressing health challenges of our time, with a particular focus on finding a cure for chronic hepatitis B. The funding will be instrumental in propelling the development of our proprietary Med-Oligoâ„¢ ASO platform. This innovative platform combines novel insights into antisense oligonucleotide (ASO) design with cutting-edge delivery conjugation technologies, significantly enhancing the efficacy of current ASO therapeutics. With this new capital, AusperBio plans to expand its clinical trials and accelerate its research aimed at treating a wide array of viral infections, metabolic disorders, genetic conditions, and immune diseases. Our modular Med-Oligoâ„¢ Platform empowers ASO therapeutics like never before, and we are eager to bring transformative therapies to patients who desperately need them. We would like to extend our gratitude to our investors for their unwavering belief in our vision. Their support not only fuels our growth but also brings us one step closer to revolutionizing treatment modalities in the biopharmaceutical landscape. As we look to the future, we remain dedicated to making significant strides toward healthier lives through innovative drug design and delivery technologies.
Revolutionizing Therapies: AusperBio Secures $37 Million in Series A Funding
Recently funded · $37.0M Series aBiopharmaceutical
Get the full AusperBio company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Aligned Marketplace | Series a | $20.0M | today |
| 2 |  Vals AI United States | Series a | $40.0M | today |
| 3 |
.png&w=3840&q=75)
